Skip to main content
. Author manuscript; available in PMC: 2014 Sep 1.
Published in final edited form as: J Immunother. 2013 Sep;36(7):382–389. doi: 10.1097/CJI.0b013e31829fb7a2

Table 1.

Patient Characteristics

Total (N=30) Arm 1 (N=15) Arm 2 (N=15) P value
Age, Median Year (range) 0.77
Median 62 (44-77) 63 (44-73) 62 (49-77)
Sex, N (%) >0.99
Male 21 (70) 11 (73) 10 (67)
Female 9 (30) 4 (27) 5 (33)
ECOG, N (%) 0.70
0 10 (33) 6 (40) 4 (27)
1 20 (67) 9 (60) 11 (73)
Prior Chemotherapy Regimens, N (%) 0.017
1 6 (20) 6 (40) 0 (0)
2 10 (33) 4 (27) 6 (40)
3 12 (40) 4 (27) 8 (53)
4 2 (7) 1 (7) 1 (7)
Metastatic Sites, N (%) >0.99
0* 4 (13) 2 (13) 2 (13)
1 6 (20) 3 (20) 3 (20)
2+ 20 (67) 10 (67) 10 (67)
*

(Locally Advanced, Recurrent)